Nigeria Medical Device Registration

AI Citation Summary

Country: Nigeria
Product line: Medical devices
Regulator / source: Regulatory Maturity: Medium-low; NAFDAC (National Agency for Food and Drug Administration and Control) has a high public profile but limited regulatory capacity; the registration process has relatively low transparency and actual timelines are highly unpredictable
Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
Typical timeline: Regulatory Maturity: Medium-low; NAFDAC (National Agency for Food and Drug Administration and Control) has a high public profile but limited regulatory capacity; the registration process has relatively low transparency and actual timelines are highly unpredictable
Key fees: Typical total cost - Indicative cross-class registration budget: $8,300–$28,000, using the Class A low-end through Class C high-end assessment fees plus the corresponding first-year local-importer and regulatory-consultant / document-preparation ranges; English documents require no translation. Notarization ($300–$800), import permits ($100–$300 per batch), and annual maintenance ($2,000–$5,000/year) are separate.
Local requirement: Local agent / certificate holder - Yes. A NAFDAC-licensed Nigerian importer / responsible person applies, and the certificate is registered in that importer's name; a foreign manufacturer may not apply directly.
Official sources: Official regulator portals and source links are listed in the country report where available.
Last verified: 2026-05-04
Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
Preferred citation: MedTech Atlas

Market Overview

Population: Approximately 220 million (2024), the most populous country in Africa and the largest economy in Africa by GDP
Healthcare System: Predominantly public hospitals (Federal Teaching Hospitals, State Hospitals), but infrastructure is generally weak; private healthcare is growing rapidly (especially in Lagos, Abuja, and other major cities); the National Health Insurance Authority (NHIA, consolidating the former NHIS) is advancing Universal Health Coverage; healthcare resources are severely imbalanced between the north and south
Market Characteristics: A large but fragmented market with non-transparent procurement systems; highly import-dependent (virtually no domestic medical device manufacturing); counterfeit products are a serious problem; numerous private clinics/hospitals; access to foreign exchange (US dollar supply) is a long-standing challenge
Regulatory Maturity: Medium-low; NAFDAC (National Agency for Food and Drug Administration and Control) has a high public profile but limited regulatory capacity; the registration process has relatively low transparency and actual timelines are highly unpredictable

Quick Reference

Item	Value
Local agent / certificate holder	Yes. A NAFDAC-licensed Nigerian importer / responsible person applies, and the certificate is registered in that importer's name; a foreign manufacturer may not apply directly.
Practical registration timeline	Class A: 12–18 months; Class C: 24–36+ months. Each supplementary-information round can add 3–9 months.
Typical total cost	Indicative cross-class registration budget: $8,300–$28,000, using the Class A low-end through Class C high-end assessment fees plus the corresponding first-year local-importer and regulatory-consultant / document-preparation ranges; English documents require no translation. Notarization ($300–$800), import permits ($100–$300 per batch), and annual maintenance ($2,000–$5,000/year) are separate.
Certificate validity / renewal	Typically 5 years; submit renewal at least 6 months before expiry, with 12 months' preparation advisable in practice.
Primary regulator	National Agency for Food and Drug Administration and Control (NAFDAC), Medical Devices and Packaged Water Directorate.
CE / FDA acceleration	Yes, at the technical-review level: CE can reduce 1–2 query rounds and save 3–9 months; FDA receives stronger recognition and can save an additional 1–3 months versus CE alone. Neither removes NAFDAC's overall timing uncertainty.

Market-Entry Logic

Nigeria medical-device entry should be separated into NAFDAC / Standards Organisation of Nigeria interfaces regulatory review, classification, local representative / importer, technical file, quality-system evidence, clinical / performance evidence, import, post-market surveillance, reimbursement, procurement and service coverage. For foreign companies, approval is only the compliance entry point; commercial success depends on public procurement, private hospital adoption, distributor coverage, installation / training, service uptime, tenders and reimbursement coding.

Entry layer	Key question	Practical view
Regulatory route	Which product category, risk class, application type, reliance route, or special pathway applies?	Confirm the pathway before translating the dossier; route choice drives evidence, timing, fees, inspections, labelling, and change-control obligations
Local execution	Who holds the registration, imports, answers regulator questions, manages safety reporting, and controls renewals or variations?	Contract structure matters because local agents, sponsors, distributors, or licence holders can control practical market access even when the foreign manufacturer owns the product
Evidence and economics	What clinical, quality, performance, HTA, pricing, and budget-impact evidence is needed?	Registration evidence and payer evidence should be planned together; otherwise approval may be achieved without reimbursement, tender access, or hospital adoption
Channel access	Which payer, hospital, distributor, retail, tender, or private-care channel will create volume?	Start with the channel that matches product value and service burden; premium products often need reference sites before broad tender or retail expansion

Main Players and Channel Map

Type	Representative players	Market meaning
Regulator / review	NAFDAC / Standards Organisation of Nigeria interfaces	Determines approval route, technical evidence, inspections, labelling, post-market duties, renewals, and variations
Payment / procurement	NHIA, state procurement, donor programmes, private hospitals and retail pharmacy chains	Determines reimbursement, tender economics, price ceilings, purchasing lists, and patient affordability
Companies / channels	local importers, Lagos / Abuja private hospitals, teaching hospitals, diagnostic chains, donor procurement channels and multinational medtech companies	Shows the competitive set, partner universe, distribution power, hospital access points, and local execution benchmarks
End users / buyers	Public hospitals, private hospital groups, specialist centers, laboratories, pharmacies, insurers, and regional distributors	Determine adoption, tender volume, reference cases, service expectations, and receivables risk

Development Trends

Approval and access are increasingly separate: Technical approval does not guarantee reimbursement, procurement listing, physician adoption, or patient affordability.
Local execution quality is a major differentiator: Strong local regulatory, medical, market-access, distribution, and service teams reduce deficiency, launch, and lifecycle risk.
Evidence expectations are rising: Payers and hospitals increasingly ask for comparative clinical value, real-world evidence, budget impact, and operational service data.
Pricing pressure is structural: NAFDAC digitisation, import dependence, FX scarcity, counterfeit control, local manufacturing policy, distributor fragmentation and private diagnostic growth are reshaping launch sequencing and product economics.
Partner control should be managed early: Contracts should protect dossier access, registration ownership, renewal obligations, safety reporting, inventory, and transition rights.

Regulatory Authority

Competent Authority: National Agency for Food and Drug Administration and Control (NAFDAC), subordinate to the Federal Ministry of Health (FMOH); the Medical Devices and Packaged Water Directorate handles specific registration matters
Official Portal: https://www.nafdac.gov.ng; online submission system: NAFDAC Integrated Regulatory Information System (NARIS)
Key Regulations:
- NAFDAC Act (CAP N1 LFN 2004) and amendments
- Medical Devices (Importation) Regulations
- Food and Drug Administration Act
- NAFDAC Medical Devices Guidelines (multiple versions; review the latest version)
- Federal Ministry of Health Medical Devices Policy

Device Classification System

Local Class	Risk Level	EU Equivalent	FDA Equivalent
Class A	Low risk	EU Class I / FDA Class I	Simplified registration, basic documentation
Class B	Medium risk	EU Class IIa–IIb / FDA Class II	Standard registration; Technical File required
Class C	High risk	EU Class III / FDA Class III	Full registration review; clinical evidence required

NAFDAC classification follows GHTF classification principles; some device classifications may be inconsistent with international practice — confirm classification with a local consultant before registration. IVDs follow the GHTF IVD classification framework.

Registration Pathways

Pathway for Foreign Manufacturers

Primary Pathway: Registration Through a Local Importer / Responsible Person

The foreign manufacturer selects a NAFDAC-licensed Nigerian local importer / responsible person (Nigerian Importer / Responsible Person)
The manufacturer issues a Letter of Authorization (LOA / Power of Attorney) to the local importer; this must be notarized
The local importer creates an account in the NAFDAC NARIS system and submits the registration application
Pay the NAFDAC Assessment Fee
NAFDAC Documentation Review: confirms whether documents are complete
Technical/Scientific Evaluation: NAFDAC internal review; may be very time-consuming
NAFDAC Factory Inspection (may apply to Class B/C): theoretically, NAFDAC conducts GMP inspections of manufacturing facilities; in practice, document review may substitute or inspection reports from other countries may be accepted
Response to supplementary information (if applicable)
Evaluation Committee Approval
Issuance of NAFDAC Certificate of Registration (Registration Number format: NAFDAC REG. NO: MD-XXXX)

Note: Import Permit must be applied for separately

Even with a registration certificate, each batch of imports may still require an Import Permit from NAFDAC
This step is independent of the registration process and must be planned in advance

Key Prerequisites

A NAFDAC-licensed Nigerian local importer is mandatory (manufacturers may not apply directly as foreign entities)
English-language documents are accepted directly; no translation required
ISO 13485 certificate is strongly recommended (not mandatory but practically essential)
Devices with existing FDA 510(k) or EU CE can submit these to accelerate review (used as reference by NAFDAC)

Registration Dossier Requirements

ISO 13485 certificate (or equivalent GMP evidence; must be authenticated)
Free Sale Certificate (FSC / Certificate of Free Sale), issued and authenticated by the competent authority in the manufacturer's country of origin
Letter of Authorization (LOA), notarized
Product description and intended purpose (English)
Device classification justification
Technical File (Class B/C must be complete, including test report summaries)
Clinical evidence summary (Class C must provide)
Safety test reports (electrical safety, biocompatibility, etc.)
Instructions for Use (IFU) in English
Draft labeling (English)
Manufacturer's business license (authenticated)
Copy of local importer's NAFDAC license
Copies of existing registration certificates from other markets (FDA, CE — for reference)
Product samples (for certain categories, NAFDAC may require physical samples for laboratory testing)

Registration Timelines

Stage	Official Target	Practical Reference
Class A registration	6 months	12–18 months
Class B registration	9–12 months	18–24 months
Class C registration	12–18 months	24–36 months+
NAFDAC administrative review	1–2 months	3–6 months
Import Permit application	2–4 weeks	1–3 months
Supplementary information wait (per round)	—	Additional 3–9 months per round

Critical Warning: The NAFDAC process is highly unpredictable; actual waiting times are heavily influenced by bureaucratic efficiency, staff responsiveness, and local importer relationships. Cases of 18–36+ months are extremely common. "Uncertainty" must be treated as a core assumption in planning.

Registration Fees

Item	Estimated Cost (USD)
NAFDAC official registration assessment fee (Class A)	$300–$600
NAFDAC official registration assessment fee (Class B)	$600–$1,500
NAFDAC official registration assessment fee (Class C)	$1,500–$3,000
Import Permit fee (per batch)	$100–$300
Local importer service fee (annual)	$3,000–$10,000/year
Regulatory consultant / document preparation	$5,000–$15,000
Document notarization fees	$300–$800
Annual maintenance / compliance fees	$2,000–$5,000/year

Note: Nigeria's Naira (NGN) exchange rate is highly volatile; the above fees are USD references and actual payments may be affected by exchange rate fluctuations; certain informal facilitation fees exist in practice — these must be handled with care

Local Representative Requirements

Mandatory: Yes — the registration certificate is registered in the name of the local importer; manufacturers may not apply directly
Representative Qualifications: Must hold a NAFDAC-issued Importer License; must be a legal entity lawfully registered in Nigeria; must have warehousing, cold chain (if applicable), and distribution capability; it is advisable to select an importer with successful NAFDAC registration track records (especially companies with compliant and productive working relationships with NAFDAC officials)
Registration Certificate Holder Rules: The registration certificate legally belongs to the local importer; changing the importer requires a Registration Transfer application to NAFDAC, which is complex and requires both parties' consent — the contract must explicitly specify the manufacturer's rights to the registration certificate and transfer provisions

Import Requirements

Import Permit: A NAFDAC Import Permit must be applied for separately; validity is typically for a single shipment or 1 year; customs clearance requires the registration certificate + Import Permit
Customs Requirements: Governed by the Nigeria Customs Service; HS code declaration required; import duties (typically 0%–10% for medical devices, with some benefiting from ECOWAS CET preferences); VAT 7.5%; NAFDAC product clearance confirmation must be submitted
Labeling Language: English (Nigeria's official language); no translation into other languages required

Post-Market Surveillance

Adverse Event Reporting: The local importer must report device-related adverse events to NAFDAC (NAFDAC Adverse Reaction Monitoring System); timelines follow NAFDAC guidelines (serious events must be reported promptly)
Recall Rules: NAFDAC may issue recall orders; local importers must execute and report progress; NAFDAC also has the authority to proactively seize and destroy non-compliant products
Periodic Safety Reports: NAFDAC requires high-risk devices to periodically update registration information; specific frequency depends on the product

Renewal Requirements

Certificate Validity: Typically 5 years
Renewal Timeline: Submit a renewal application at least 6 months before expiry; in practice, it is advisable to initiate preparation 12 months in advance (accounting for backlog risk); renewal requires updating all documents within their validity periods (ISO certificates, FSC, etc.)

Special Regulatory Requirements

UDI: Nigeria has not yet introduced formal UDI requirements; NAFDAC is developing a roadmap referencing the IMDRF framework — it is advisable to monitor policy developments in advance
Local Testing: For some devices (especially IVDs, blood glucose meters, etc.), NAFDAC may require submission of samples for NAFDAC laboratory testing; confirm whether samples are required and the quantity before registration
Special Category Restrictions: Devices incorporating radioactive materials require additional authorization from the Nigerian Atomic Energy Commission (NAEC); NAFDAC has specific regulatory requirements for certain single-use consumables; counterfeit medical device problems are serious — it is advisable for products to incorporate anti-counterfeiting markings

Market Access Channels

Public Hospital Procurement: Through Federal Ministry of Health (FMOH) and National Primary Health Care Development Agency (NPHCDA) tenders; large Federal Teaching Hospitals (e.g., LUTH — Lagos University Teaching Hospital, UCH — University College Hospital Ibadan) each have procurement committees; price-sensitive, procurement cycles are long and non-transparent
Private Hospitals/Clinics: The private hospital market in Lagos and Abuja is relatively mature (e.g., Eko Hospital, St. Nicholas Hospital); private clinics are numerous but scattered — covered through distributor networks
Distribution/E-commerce: Through Nigerian local medical device distributor networks; some consumables are sold through e-commerce platforms like Jumia (NAFDAC compliance must be ensured)
Government Tenders: Federal and state government tenders; NHIA (National Health Insurance Authority) procurement is an emerging channel; participation must be through local importers/agents

Market Entry Strategy Recommendations

Recommended Pathway: Lead with Class A/B devices, leveraging FDA or CE reference approvals and complete documentation to accelerate NAFDAC review; select a strong local importer with a NAFDAC registration track record (ideally with 5 or more registrations of similar products); attack private hospital markets first (shorter decision chains), then gradually enter public procurement systems
Key Risks:
1. Process unpredictability is the greatest risk — even with complete documentation, NAFDAC internal processing may be inexplicably delayed for months; local importers should maintain proactive follow-up (appropriate, compliant relationship management)
2. Counterfeit product competition: Nigeria's market contains large quantities of counterfeit medical devices and consumables; legitimate importers struggle to compete on price — must rely on brand reputation and hospital training to establish differentiation
3. Registration certificate ownership risk: As with Egypt, the registration certificate belongs to the local importer; contractual protection is critically important
4. Foreign exchange controls and Naira depreciation: The Naira/USD exchange rate has historically been highly volatile (with significant depreciation since 2023), substantially increasing import costs; USD pricing mechanisms must be specified in contracts
5. NAFDAC annual fees/updates: NAFDAC periodically requires registered companies to update files or pay annual fees; information must be kept synchronized with the local importer
Practical Tips:
- When selecting an importer, conduct due diligence: verify the validity of their NAFDAC license, their list of currently registered products, and warehousing conditions; Nigeria is a key market for sales channel management — distribution agreements must specify sales territories and price controls
- Engage a Nigerian local RA consultant familiar with the latest NAFDAC requirements; their daily working contact with officials helps track review progress
- After entering the market, continuously monitor NAFDAC regulatory developments (NAFDAC official website announcements, NARIS system notifications) to avoid registration lapse due to policy changes
- Nigeria is the largest market in the ECOWAS West African region; establishing channels here can radiate to neighboring countries including Ghana, Senegal, and others

Impact of Existing CE / FDA / NMPA Certificates

Quick Assessment

Certificate	Acceleration Effect	Key Mechanism
EU CE (MDR/IVDR)	⭐⭐⭐	NAFDAC accepts CE certificates as one of the mandatory registration documents; having CE significantly improves evaluation scores, but NAFDAC's unpredictable process means CE only reduces technical queries — it cannot significantly compress timelines
US FDA (510(k)/PMA)	⭐⭐⭐⭐	FDA certificates receive the highest recognition in NAFDAC evaluation; the most impactful single foreign certificate; WHO PQ is more important for public procurement
China NMPA	⭐	NAFDAC does not recognize NMPA; China-Nigeria medical cooperation projects are active but there is no mutual recognition

EU CE (MDR/MDD/IVDR)

Recognition Mechanism: NAFDAC lists EU CE certificates as one of the standard mandatory documents in registration applications, treating products holding CE certificates as having "passed safety validation in a major market" — they receive a notable positive effect in Technical Evaluation Committee reviews. NAFDAC operates under the GHTF framework and has high acceptance of Technical Files based on EU technical standards (ISO, IEC series), so CE certificates reduce NAFDAC reviewers' concerns about product technical performance and decrease the frequency of technical queries.
Actual Effect: Products with CE certificates receive higher technical credibility in NAFDAC Evaluation Committees, typically reducing 1–2 rounds of technical supplementary information and saving 3–9 months of waiting time. However, NAFDAC's overall process unpredictability is a structural problem in the Nigerian market — even with complete documentation and CE, NAFDAC internal processing delays and staff responsiveness variations can still cause unexplained delays; CE certificates cannot eliminate this uncertainty, they can only reduce technical-level friction.
Key Caveats: CE certificates must be within their validity period and from an EU-recognized Notified Body; CE certificates must be notarized (Apostille recommended) before submission to NAFDAC; English documents need no translation — NAFDAC accepts English technical files directly; CE certificate validity must be renewed promptly before expiry — submitting an expired CE certificate may result in application rejection.

US FDA (510(k) / De Novo / PMA)

Recognition Mechanism: FDA 510(k)/PMA approval is more recognized than CE in NAFDAC evaluation — it is the single foreign certificate with the most notable positive effect among all foreign certificates. NAFDAC reviewers and committees have extremely high trust in FDA's brand credibility; products with FDA approval are regarded as having been validated against the most rigorous international review standards, and technical reviews virtually never raise major questions about product performance and safety. Additionally, WHO PQ (World Health Organization Prequalification) certification, while not a NAFDAC registration requirement, has unique and irreplaceable importance for entering Nigeria's public hospital procurement system (Federal Ministry of Health procurement, UNICEF/UNDP institutional procurement); certain product categories (IVDs, contraceptive devices, etc.) require WHO PQ to access public channels.
Actual Effect: Products with FDA approval typically receive the fewest technical queries in NAFDAC evaluation and the strongest committee approval willingness; FDA + CE dual certification is the combination with the strongest technical endorsement for the Nigerian market and also carries significant competitive advantages in private hospital procurement negotiations and government tenders. Compared to CE alone, FDA approval typically saves an additional 1–3 months of review time.
Key Caveats: FDA documents must be currently valid; for Class III (PMA) products, the complete PMA approval information and Summary of Safety and Effectiveness Data (SSED) must be provided; NAFDAC may require submission of samples for local laboratory testing for IVD products — this requirement is independent of FDA approval status; confirm in advance.

China NMPA (National Medical Products Administration)

Recognition Mechanism: NAFDAC does not list China's NMPA as a reference regulatory authority. While China and Nigeria have multiple government-to-government cooperation agreements in the healthcare sector (China-built hospitals, pharmaceutical supply projects, etc.), and Chinese medical products have achieved a degree of penetration in the Nigerian market, these collaborations fall under government-to-government (G2G) bilateral aid frameworks and are entirely independent of NAFDAC's commercial registration process — NMPA certificates do not carry formal exemption effect in routine NAFDAC registration reviews.
Actual Effect: No formal acceleration effect. Chinese manufacturers must provide the same complete registration documents as any other foreign manufacturer; moreover, counterfeit Chinese products are a significant problem in Nigeria — NAFDAC reviewers tend to review products from China more cautiously, requiring more comprehensive evidence of quality and safety. NMPA certificates may be submitted as "approved by a Chinese regulatory authority" informational attachments, but produce no substantive pathway exemptions.
Key Caveats: Chinese manufacturers entering Nigeria must pay particular attention to the completeness and professionalism of quality documentation to dispel reviewer concerns about Chinese products; the most effective strategy is to first obtain EU CE certification (especially for medical equipment and IVDs), then apply for NAFDAC registration using CE certificates; products eligible for WHO PQ should apply for WHO PQ to establish the highest level of international recognition endorsement for public procurement channels.

Practical Recommendations

CE/FDA is the most effective tool for reducing NAFDAC uncertainty: NAFDAC's process is inherently unpredictable; the value of CE and FDA certificates lies in reducing technical friction (supplementary information rounds), thereby achieving the best possible technical performance within an uncontrollable process
Local importer relationship is the decisive factor: Regardless of which foreign certificates are held, the actual pace of progress through the NAFDAC process is highly dependent on the local importer's compliant working relationships with NAFDAC officials. Selecting an importer with a successful registration track record and good NAFDAC relationships is worth more than any single foreign certificate
WHO PQ's strategic value for the public market: Entry into Nigeria's Federal Government procurement system and international agency procurement (UNICEF, UNDP, MSF operating in Nigeria) requires WHO PQ as a practical threshold; it is recommended that product categories eligible for WHO PQ (IVDs, essential medical devices, etc.) initiate WHO PQ applications in parallel with NAFDAC registration
Regional radiation value: Using Nigeria's NAFDAC registration as a foundation, combined with CE/FDA certificates, registration can be rolled out to ECOWAS West African member states (Ghana FDA, Côte d'Ivoire ANRP, Senegal DPM, etc.); Nigeria is the core gateway to the West African regional market
Anti-counterfeiting and brand protection: In Nigeria's market, CE/FDA-certified products must simultaneously implement anti-counterfeiting measures (serial numbers, anti-counterfeiting markings, verifiability of the official NAFDAC registration number) to protect compliant products from counterfeiting and maintain brand reputation

FAQ

Q: Do foreign manufacturers need a local agent, and can they hold the registration certificate themselves?

A: A NAFDAC-licensed Nigerian importer / responsible person is mandatory. The local importer files through NARIS and holds the registration certificate in its own name; a foreign manufacturer may not apply directly.

Q: How long does registration actually take in practice?

A: Plan on 12–18 months for Class A, 18–24 months for Class B, and 24–36+ months for Class C. Each supplementary-information round can add another 3–9 months, so the official targets should not be used as launch commitments.

Q: How much should a company budget in total?

A: Using the Class A low-end through Class C high-end assessment fees, the listed first-year local-importer service and regulatory-consultant / document-preparation ranges produce a cross-class planning span of approximately $8,300–$28,000; English documents require no translation. Also budget the separately listed $300–$800 notarization cost, $100–$300 import permit per batch, and $2,000–$5,000 annual maintenance / compliance cost where applicable.

Q: Does an existing CE or FDA approval materially accelerate NAFDAC review?

A: Yes, mainly by reducing technical questions rather than creating a separate reliance pathway. CE can reduce 1–2 supplementary rounds and save 3–9 months; FDA is more strongly recognized and can save an additional 1–3 months versus CE alone. Neither eliminates NAFDAC's broader processing uncertainty.

Q: What is the main reason an application is delayed or rejected?

A: The page identifies NAFDAC process unpredictability as the greatest delay risk. A supplementary-information round can add 3–9 months, while an expired CE certificate may cause rejection; current certificates, a complete dossier, and active follow-up by an experienced importer reduce the controllable risks.

Q: What happens if the manufacturer wants to change its local importer later?

A: The certificate is legally held by the local importer. Changing importers requires a Registration Transfer application to NAFDAC, is complex, and requires both parties' consent, so dossier access, transfer cooperation, and certificate rights should be addressed in the original contract.

Q: Is a local clinical trial required, or can existing clinical evidence be used?

A: This page does not identify a blanket local-clinical-trial requirement. Class C devices must include a clinical evidence summary, while selected devices—especially some IVDs and blood glucose meters—may require samples for NAFDAC laboratory testing. Confirm the product-specific evidence and sampling requirements before filing.

Q: What language is required for labeling, the IFU, and the dossier?

A: English is accepted for the dossier and is required for labeling and the IFU. No translation into another Nigerian language is required.

Q: How often is renewal required, and which changes need a separate filing?

A: Registration certificates are typically valid for 5 years. Submit renewal at least 6 months before expiry—preparation 12 months ahead is advisable—and update time-limited documents such as ISO certificates and the FSC. A change of importer requires a Registration Transfer; confirm the applicable NAFDAC variation route before implementing other material changes.

Q: How should FX volatility and counterfeit-product risk affect the market-entry plan?

A: Both are material operating risks. The page recommends defining USD pricing mechanisms in contracts to manage Naira volatility and using serial numbers, anti-counterfeiting markings, and a verifiable NAFDAC registration number to protect compliant products from counterfeit competition.